United States · FDA National Drug Code directory
Vyleesi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0713-0897_437e6c45-dfb9-35ec-e063-6394a90a7874
- Product NDC
- 0713-0897
- Form
- INJECTION
- Composition / generic term
- bremelanotide
- Labeler
- Cosette Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251112
- Source listing expiry
- 20261231
Source-listed ingredients
- BREMELANOTIDE ACETATE — 1.75 mg/.3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 SYRINGE in 1 CARTON (0713-0897-04) / .3 mL in 1 SYRINGE (0713-0897-06) · 0713-0897-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →